Genvivo
Personalizing Off-the-shelf, Systemic, Cancer Immunotherapy
GenVivo will make first- and best-in-class immune therapies that are immediately and easily deployable, highly effective, and which improve survival and quality of life beyond current therapies.
Creating innovative treatment options
Versatile Targeted, Non-Replicating Vector Platform
Our proprietary platform aims to set new standards in safety, efficacy, specificity of target and flexibility in mRNA payloads.

Be part of the
GenVivo team
Our philosophy is to provide growth
opportunities and a comprehensive
compensation and benefits package to
support our most valued assets, our
employees.